| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
Form 4: Blackburn Kelly, EVP, Clinical Development
Granted 19,100 Stock Option (Right to Buy) |
| 23 Oct 2026 |
Form 4: De Rosch Mark, EVP, RA and GA and PgM
Granted 19,100 Stock Option (Right to Buy) |
| 23 Oct 2026 |
Form 4: Winton Matthew, Chief Commercial and Business
Granted 19,100 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Boger Joshua S, Director
Bought 955,414 shares ($3M) · Acquired 955,414 Series B Warrants (Open Market Purchase) · Acquired 955,414 Series C Warrants (Open Market Purchase) |
| 10 Jun 2026 |
Form 4: Zavrl Frank, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Sabbagh Marwan, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Quigley David, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Poulton Jeffrey V., Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Hollingsworth Jane H, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Gregoire Sylvie, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Boger Joshua S, Director
Granted 8,150 Stock Option (Right to Buy) |
| 10 Jun 2026 |
Form 4: Alam John J, Director
Granted 8,150 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Winton Matthew, Chief Commercial and Business
Granted 30,000 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Gregoire Sylvie, Director
Granted 75,000 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Elder William Robert, CFO, GC & Secretary
Granted 30,000 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: De Rosch Mark, EVP, RA and GA and PgM
Granted 30,000 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Blackburn Kelly, EVP, Clinical Development
Granted 30,000 Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Alam John J, Director
Granted 75,000 Stock Option (Right to Buy) |
| 05 Dec 2025 |
Form 4: Quigley David, Director
Granted 16,200 Stock Option (Right to Buy) |
| 19 Nov 2025 |
Form 4: Winton Matthew, Chief Commercial and Business
Bought 3,500 shares ($29.5K) · Bought 1,500 shares ($11.9K) |
Loading...